Seroepidemiologic Survey of Varicella-Zoster Virus in Korean Adults Using Glycoprotein Enzyme Immuno Assay and Fluorescent Antibody to Membrane Antigen Test
Annals of Dermatology2011Vol. 23(1), pp. 39–39
Citations Over Time
Abstract
Most (90.2%) Korean adults ≥40-years-of-age have a protective level of gpEIA antibody against varicella and 98.6% were FAMA seropositive. The GMT of gpEIA antibody was significantly increased with age, and was higher in adults with a history of HZ.
Related Papers
- → Attenuation of Antibody Titers from 3 to 6 Months after the Second Dose of the BNT162b2 Vaccine Depends on Sex, with Age and Smoking Risk Factors for Lower Antibody Titers at 6 Months(2021)31 cited
- → Changes in skin-sensitizing antibody titer after injections of aqueous pollen extract(1969)33 cited
- → Screening of antibodies to varicella-zoster virus in leukemic patients: Comparison of commercial methods of enzyme-immunoassay and fluoroimmunoassay(1988)3 cited
- → Anti-Human Growth Hormone (HGH) Antibody Determination in HGH-treated Patients(1978)2 cited
- The dynamic change of chicken serum antibody after inject IgY(2012)